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Abstract Utilising the patch-clamp recording technique we
have demonstrated for the ¢rst time the e¡ects of hypoxia on
the background current in pulmonary arterial endothelial cells.
Electrophysiological studies revealed the presence of a novel
oxygen-sensitive, non-selective cation conductance (INSC) in
these cells. The inward component of INSC was signi¢cantly
potentiated by hypoxia. Both the inward and outward compo-
nents of INSC were inhibited by both La3
+ and Gd3+. Hypoxic
activation of INSC may provide an important Ca2
+ in£ux path-
way essential for the release of a pulmonary-selective vasocon-
strictor pivotal to the sustained phase of hypoxic pulmonary
vasoconstriction. / 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Pulmonary arterial blood gas tension in the lungs is opti-
mised by the matching of local perfusion to local ventilation
and is achieved by a mechanism known as hypoxic pulmonary
vasoconstriction (HPV). It is generally accepted that, in the
small pulmonary arteries (200^400 Wm diameter), HPV is a
biphasic response consisting of phase 1, an initial transient
constriction, followed by phase 2, a sustained but slowly de-
veloping constriction [1,2]. The endothelium has been shown
to be essential for phase 2 of HPV [1,3,4] and many reports
also indicate removal of the endothelium attenuates phase 1 of
HPV [1,4^6]. The importance of the endothelium in HPV is
further compounded by the opinion that phase 2 constriction
of HPV is physiologically more relevant than phase 1, since
phase 2 is sustained [2].
Recently it has been suggested that phase 2 of HPV may
depend upon endothelial release of a vasoconstrictor [1,2,7,8],
since, during hypoxia, removal of the endothelium decreases
tone to below the level of pretone [1]. It is also known that
release of vasoactive mediators by endothelial cells is closely
associated with their membrane potential (Em) and conse-
quently their intracellular Ca2þ concentration [9,10], with hy-
perpolarisation driving entry of extracellular Ca2þ [10]. It is
therefore interesting to note that phase 2 constriction of HPV
has been shown to occur as a result of elevated Ca2þ entry
[8,11,12], and recently several reports have demonstrated that
hypoxia can indeed release vasoconstricting factors from the
pulmonary endothelium [7,13,14].
Electrophysiological studies aimed at elucidating the ion
channels responsible for maintaining the Em of pulmonary
arterial endothelial cells (PAEC) have mainly been con¢ned
to cultured cell models and those from larger conduit arteries
[15,16]. These are not ideal models with which to study the
ions channels of endothelial cells of small pulmonary arteries
since it has been shown that main pulmonary arteries respond
to hypoxia with a transient constriction followed by full re-
laxation [17^20], indicating the absence of the mechanism(s)
responsible for phase 2 HPV within the endothelium of these
arteries. Di¡erences are also known to exist between the elec-
trophysiological pro¢le of cells from cultured and freshly iso-
lated preparations, where changes or loss in channel expres-
sion is thought to occur [21^23].
We have previously shown that endothelial cells freshly
isolated from small pulmonary arteries possess a Kþ conduc-
tance [24]. However, the nature of the background currents of
these pulmonary endothelial cells, freshly isolated from resis-
tance arteries, is unknown although a non-selective cation
channel has been reported in pulmonary endothelial cell lines
[16]. This channel is thought to represent an important Ca2þ
in£ux pathway, with in£ux driven by hyperpolarisation
[15,25,26], that may in turn in£uence release of vasoactive
mediators.
The aim of the present study was to identify the nature of
the background currents in endothelial cells freshly isolated
from small pulmonary arteries of the rat. Hypoxia is thought
to cause a rise in intracellular Ca2þ in these cells coupled to
release of a pulmonary-selective vasoactive mediator that is
essential for phase 2 of HPV. Since these currents may under-
lie the oxygen-sensing mechanisms present in the endothelium
of small pulmonary arteries that initiate sustained HPV, it was
important to determine the hypoxia sensitivity of these cur-
rents.
2. Materials and methods
2.1. Cell isolation
Male Wistar rats (V200 g; Harlan, UK) were killed by an overdose
of i.p. sodium pentobarbitone (Rhone Merieux, Ireland). Following
removal and cleaning, small pulmonary arteries (200^400 Wm in diam-
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eter) were transferred to phosphate-bu¡ered saline (PBS) (Life Tech-
nologies Ltd., UK) containing 0.2 mg ml31 dithiothreitol and 0.2 mg
ml31 papain (from Carica papaya latex). The vessels were then agi-
tated in an oscillating water bath at 37‡C for 20 min. Bovine serum
albumin (BSA) (2.0 mg ml31) was then added. Single PAEC were
released by gently triturating with a ¢re-polished Pasteur pipette. Cells
were stored at 4‡C and were viable for 3^4 h.
2.2. Electrophysiology
To investigate the electrophysiological characteristics of individual
PAEC, Em and membrane currents were recorded utilising the perfo-
rated-patch con¢guration [27] of the patch-clamp technique [28], using
an Axopatch 200B patch-clamp ampli¢er (Axon Instruments Inc.,
USA). Patch pipettes were fabricated from borosilicate glass capilla-
ries (Harvard Apparatus, UK) using a vertical microelectrode puller
(PP-83, Narishige Scienti¢c Instruments, Japan) and ¢re-polished.
Fire-polished patch pipettes had resistances of 5^7 M6. Data were
¢ltered at 5 kHz, digitised at 24 kHz and recorded o¡-line with a
modi¢ed DAT recorder (Sony DTC-A8, Sony Corp., Japan). Data
were analysed using pClamp software (version 6.04, Axon Instru-
ments Inc.).
In order to investigate the nature of the background currents, cells
were perfused at room temperature (V22‡C) with a Kþ-free bath
solution that consisted of (in mM): 145 NaCl, 0.5 MgCl2, 1.5 CaCl2,
5.5 D-glucose, 10 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid
(HEPES); pH 7.4 (NaOH) and dialysed with a Kþ-free patch pipette
solution that contained (in mM): 140 CsCl, 1 MgCl2, 2.3 CaCl2,
5 ethylene glycol-bis(L-aminoethylether)-N,N,NP,NP-tetraacetic acid
(EGTA), 10 HEPES and 240 Wg ml31 amphotericin B (stock, 20 mg
ml31 in dimethyl sulfoxide); pH 7.3 (CsOH). To determine the ionic
permeability of the inward component of the background currents,
extracellular Naþ was replaced with equimolar Csþ or NMDGþ. The
PO2 of the extracellular bathing solution was monitored using an O2-
sensitive microelectrode (ISO2, World Precision Instruments, UK).
Hypoxic solutions were achieved by bubbling bath solutions with
100% N2 to achieve a PO2 of V25 mmHg. 2P,4P-Dichlorobenzamil
(DCB) was obtained from Biomol Research Laboratories Inc., USA
and dissolved in dimethyl sulfoxide as a 50 mM stock. All other
reagents were purchased from BDH-Merck Ltd., UK or Sigma-Al-
drich Company Ltd., UK.
For voltage step experiments, cells were maintained at a holding
potential of 0 mV and membrane currents were recorded in response
to 1000 ms voltage steps from 3150 mV to +50 mV in 20 mV incre-
ments. The mean steady-state current, measured as the mean current
during the last 100 ms of each voltage step, was used to construct a
current^voltage (I^V) relationship. For voltage ramp experiments cells
were voltage-clamped at 350 mV and subjected to a ramp protocol
applied at a frequency of 0.2 Hz which consisted of an initial hyper-
polarising ramp (30.71 V s31) to 3100 mV, followed by a depolaris-
ing ramp (0.75 V s31) to +50 mV, ending with a repolarising ramp
Fig. 1. A^D: Background currents recorded in PAEC under Kþ-free, perforated-patch conditions. A: A typical family of currents recorded in
response to voltage steps from 3150 mV to +50 mV from a holding potential of 0 mV (see inset), which displayed little time-dependent activa-
tion and inactivation during the course of the voltage step. In the example shown here, spontaneous transient inward currents appear to be
superimposed on the whole-cell membrane currents at more hyperpolarised potentials. B: Mean steady-state I^V relationship recorded for the
background current (pA pF31 ; n=7). Note the mild inward recti¢cation at very hyperpolarised potentials. C: E¡ects of extracellular cation
substitution on the background currents. Typical families of currents evoked by voltage steps from 3150 mV to +50 mV in 20 mV increments
from a holding potential of 0 mV, measured in a Naþ extracellular solution (left panel). Ionic substitution of extracellular Naþ for NMDGþ
caused a marked decrease in inward current (centre panel), while replacement with Csþ induced a small increase in inward current (right panel).
However, ionic substitution of the major extracellular cation had no e¡ect on the outward component of the background current. D: Typical
I^V relationships derived from depolarising voltage ramps from 3100 mV to +50 mV recorded in an Naþ extracellular solution and after ionic
substitution of extracellular Naþ for either NMDGþ or Csþ.
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(30.71 V s31) back to the holding potential. I^V relationships were
constructed using the mean currents activated from three consecutive
depolarising voltage ramps from 3100 mV to +50 mV. Comparison
of currents before and after ion substitution or application of drugs
was made using the mean current amplitude from three consecutive
voltage ramps at 390 mV (I390). I390 were normalised either to cell
capacitance or to the peak outward inward current at 3100 mV. Data
are expressed as meanR standard error of the mean. Statistical com-
parisons were made using an unpaired Student’s t-test, with di¡er-
ences considered signi¢cant at P6 0.05.
3. Results
To investigate the nature of the background currents
present in PAEC, perforated-patch voltage-clamp recordings
were carried out with a Csþ pipette solution and Kþ-free bath
solutions to eliminate Kþ currents. Membrane currents elic-
ited in response to voltage steps demonstrate the absence of
both time-dependent activation and inactivation during the
course of the voltage steps (Fig. 1A). However, examination
of the mean steady-state I^V relationship indicates very mild
inward recti¢cation in addition to the presence of erratic
spontaneous transient inward currents superimposed on the
whole-cell membrane currents at more hyperpolarised poten-
tials (Fig. 1B).
In order to examine the nature of the charge carrier of this
background current, extracellular Naþ was substituted with
equimolar concentrations of either NMDGþ or Csþ. Ionic
substitution of extracellular Naþ with NMDGþ dramatically
reduced the magnitude of the inward component of back-
ground currents while replacement of Naþ with Csþ caused
a small increase in the magnitude of the inward component of
background currents evoked by both voltage steps and vol-
tage ramps (Fig. 1C and D). Ionic substitution of Naþ for
NMDGþ or Csþ caused changes in the I390 of voltage ramp-
induced currents from 313.94 R 3.77 pA pF31 (n=8) to
34.68 R 1.47 pA pF31 (n=8; P6 0.05) and 316.01 R 4.44
pA pF31 (n=4), respectively. Furthermore, ionic substitution
of Naþ for NMDGþ or Csþ also signi¢cantly shifted the
experimental reversal potential from 37.22R 1.12 mV
(n=17) to 337.38 R 6.88 mV (n=8; P6 0.0001) and
31.11 R 0.90 mV (n=7; P6 0.005), respectively. Since the
outward current is of similar magnitude under each condition,
Fig. 2. E¡ects of hypoxia and trivalent cations on the INSC recorded from PAEC under Kþ-free perforated-patch conditions. A: Voltage steps
from 3150 mV to +50 mV in 20 mV increments from a holding potential of 0 mV induced a typical family of membrane currents (left panel),
which were signi¢cantly potentiated in the presence of hypoxia (PO2V25 mmHg). Note the erratic nature and appearance of time-dependent
activation of these currents at more hyperpolarised potentials. B: Typical examples of I^V relationships derived from depolarising voltage
ramps from 3100 mV to +50 mV under normoxic (PO2V150 mmHg) and hypoxic conditions. Note the increase in the magnitude of inward
currents upon application of hypoxia. C: Representative examples of I^V relationships derived from depolarising voltage ramps from 3100 mV
to +50 mV in the absence and presence of 100 WM La3þ. Note the inhibition of both the inward and outward components of the background
currents in the presence of 100 WM La3þ. D: Data summarising the e¡ects of hypoxia (n=4), 100 WM Gd3þ (n=3) and 100 WM La3þ (n=3)
on the I390 (normalised to peak inward current) when compared to control conditions (n=10). ** Indicates P6 0.01 when compared to con-
trol.
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this would indicate that it is movement of extracellular cations
into the cell that is responsible for the inward component of
the background current. Together, the change in amplitude of
inward currents and the shifts in experimental reversal poten-
tial indicate that the background current may be carried by a
non-selective cation channel with a permeability sequence of
CsþsNaþENMDGþ.
Perforated-patch experiments were carried out to determine
whether hypoxia had any e¡ects on the non-selective cation
currents (INSC) identi¢ed in PAEC. In response to voltage
steps, membrane currents were markedly potentiated under
hypoxic conditions (PO2V25 mmHg) when compared to cur-
rents under normoxic conditions (PO2V150 mmHg; Fig.
2A). The example shown here shows a family of background
currents that appear more erratic at hyperpolarised potentials.
Upon application of hypoxia, the inward components of
background currents were augmented, displayed some time-
dependent activation and became very erratic at more hyper-
polarised potentials (Fig. 2A). A typical example of an I^V
relationship derived from depolarising voltage ramps demon-
strates that membrane currents are activated under hypoxic
conditions in endothelial cells freshly isolated from small pul-
monary arteries (Fig. 2B). The mean I390 of voltage ramp-
induced currents (normalised to peak inward current) was
signi¢cantly increased by V30% under hypoxic conditions
when compared to those under normoxic conditions (Fig.
2D). In order to con¢rm that the hypoxia-activated back-
ground current was due to activation of INSC and not a
Naþ/Ca2þ exchanger, experiments were carried out in the
presence of DCB, a selective Naþ/Ca2þ exchange inhibitor
[29,30]. DCB (50 WM) had no signi¢cant e¡ect on the I390
of the INSC (n=4) and also failed to attenuate the hypoxic
activation of INSC (n=3; data not shown) when compared to
control conditions. These data indicate that Naþ/Ca2þ ex-
change was not responsible for the hypoxia-activated back-
ground current.
Trivalent cations such as Gd3þ and La3þ have been shown
to inhibit INSC [31^33] and La3þ has also been shown to in-
hibit the endothelium-dependent phase of HPV [34]. It was
therefore important to determine the e¡ects of both Gd3þ and
La3þ on the INSC identi¢ed in PAEC. Perforated-patch re-
cordings of INSC evoked in response to voltage ramps were
signi¢cantly attenuated by the addition of either 100 WM La3þ
or Gd3þ. An I^V relationship constructed from depolarising
voltage ramps demonstrates attenuation of both the inward
and outward components of the INSC in the presence of 100
WM La3þ (Fig. 2C). The I390 (normalised to peak inward
current) of voltage ramp-induced currents were attenuated
by Gd3þ and La3þ by V70% and V60%, respectively (Fig.
2D). Together these results suggest that the hypoxia-sensitive
INSC identi¢ed in PAEC may be inhibited by the trivalent
cations La3þ or Gd3þ. The identi¢cation of this novel hypox-
ia-sensitive INSC may have important implications for eluci-
dating the oxygen-sensing mechanisms underlying the endo-
thelium-dependent phase of HPV.
4. Discussion
This study provides the ¢rst observation of a hypoxia-acti-
vated INSC in endothelial cells of small pulmonary arteries ;
those vessels that are responsible for mediating HPV.
This ¢nding is of major importance since the endothe-
lium of these small arteries is essential for the physiological-
ly important, sustained phase of HPV and may help to eluci-
date the oxygen-sensing mechanisms which underlie this
response.
Under Kþ-free conditions, extracellular cationic substitu-
tion experiments revealed that the background currents of
the PAEC recorded within this study possessed a permeability
sequence of CsþsNaþENMDGþ similar to that of INSC
present in other cell types [10,16,35]. In addition, the electro-
physiological pro¢le of the INSC of PAEC displayed little vol-
tage-dependent activation and inactivation, a ¢nding also con-
sistent with the properties of other INSC [35]. In contrast to
other INSC, voltage step experiments revealed spontaneous
transient inward currents that were superimposed on the
whole-cell currents at hyperpolarised potentials and also
showed some weak inward recti¢cation. Weak inward recti¢-
cation has been observed in currents recorded from endothe-
lial cells isolated from intrapulmonary arteries [36] and guin-
ea-pig endocardial cells [37] and has also been observed in
vascular endothelial cells after activation by mechanical
stretch [38,39]. Why the INSC observed in this study demon-
strate weak inward recti¢cation is unclear. However, it is pos-
sible that a component of stretch-induced INSC may be acti-
vated under our conditions [39].
The inward component of the INSC identi¢ed in PAEC was
signi¢cantly potentiated after the application of hypoxia. The
augmentation of this novel hypoxia-sensitive current may
have important implications for the role of the endothelium
in the control and release of the vasoactive mediators respon-
sible for phase 2 of HPV. The hypoxia-sensitive INSC identi-
¢ed in PAEC may therefore provide an important Ca2þ in£ux
pathway since the INSC identi¢ed in other preparations have
been shown to provide Ca2þ entry pathways [33,40]. In sup-
port of the existence of a hypoxia-activated Ca2þ in£ux path-
way in these cells are the observations that cytosolic free cal-
cium is increased upon application of hypoxia in PAEC
[41,42]. Consistent with this notion, the INSC identi¢ed in
PAEC could be attenuated by the trivalent cations La3þ
and Gd3þ, which have both previously been shown to block
INSC of endothelial cells of the human umbilical vein [40] and
guinea-pig endocardium [33]. Similar concentrations of La3þ
to those used in this study have been reported to inhibit the
endothelium-dependent, second phase of HPV [34]. It is there-
fore possible that the hypoxia-activated INSC is responsible for
the La3þ-sensitive Ca2þ in£ux pathway essential for the sus-
tained elevation of Ca2þ required for phase 2 of HPV. This
sustained rise in the intracellular Ca2þ concentration may in
turn lead to release of endothelium-derived constricting fac-
tors [13,14], or indeed endothelin-1 which has been implicated
in HPV [43,44], in order to maintain pulmonary vasoconstric-
tion.
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